Market Cap 8.74M
Revenue (ttm) 4.72M
Net Income (ttm) -3.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -71.61%
Debt to Equity Ratio 0.00
Volume 8,500
Avg Vol 292,808
Day's Range N/A - N/A
Shares Out 8.17M
Stochastic %K 19%
Beta 1.11
Analysts Strong Buy
Price Target $5.00

Company Profile

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune su...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3 Carlton South, Carlton, Australia
SuperGreenToday
SuperGreenToday Jun. 17 at 8:11 AM
1 · Reply
Tryitin
Tryitin Jun. 16 at 10:06 PM
$IMRN 4 hr candle is showing double bottom at 1.05 and has been consolidating above 1 for the past 2+ weeks. A rise here is imminent in the coming days/weeks with or without news.
0 · Reply
VikaDelic
VikaDelic Jun. 12 at 1:04 PM
$IMRN short interest will update again based on end of today. Someone isn’t finding shares and is losing their patience, probably try to whipsaw it before they begin paying for what they can’t find with fud tactics. Very limited playbook when you look at the shares available and borrow rates, especially after the Australian exchange sent the inquiry recently about unusual trading. Ask yourself why someone would risk manipulating a stock under 10 mil with multiple DOD contracts recently awarded, something is probably coming that justified the risk
0 · Reply
Tryitin
Tryitin Jun. 10 at 3:18 PM
$IMRN Absolutely. This is consolidating heavily above 1.1 levels just like last time before it raised heavily. Round 2 is in the corner in the coming days. PAYtience will pay here!
1 · Reply
VikaDelic
VikaDelic Jun. 10 at 1:12 PM
$IMRN wow- 532000 shares short! 10 days to cover. Less than 100K shares to borrow going on a week now, borrow rate still over 30% ⏰ tick tock
0 · Reply
Tryitin
Tryitin Jun. 6 at 3:04 PM
$IMRN Absolutely. Even inspite of thick red market, this had a strong 4 hr green candle. Consistent higher lows chart pattern in a bullish wedge and is consolidating for the next leg up in the coming days IMO.
0 · Reply
KUMO2026
KUMO2026 Jun. 6 at 10:21 AM
$IMRN very nice short on this manufactured poop stock the irony play pills may prevent poopy pants, but the stock took a big ugly dump like i said it would im never wrong kids
1 · Reply
Tryitin
Tryitin Jun. 5 at 1:09 PM
$IMRN Absolutely. Just a matter of time. 1.2 is good support and should reverse from there IMO.
1 · Reply
t_baggin_u
t_baggin_u Jun. 4 at 4:37 AM
$IMRN So you're the new board pumper now? Welcome. But that won't change much.
0 · Reply
Tryitin
Tryitin Jun. 3 at 7:41 PM
$IMRN Need some volume or action here. Looks better than yesterday close. Wen news PR drop on this one? Lets Go!
0 · Reply
Latest News on IMRN
Immuron Double Digit 3Q Sales Growth

Fri, 17 Apr 2026 06:00:00 -0400 - 2 months ago

Immuron Double Digit 3Q Sales Growth


Immuron Reports Continued Sales Growth

Mon, 19 Jan 2026 06:00:00 -0500 - 5 months ago

Immuron Reports Continued Sales Growth


Why Is Immuron Stock (IMRN) Down Today?

2025-12-10T13:49:49.000Z - 6 months ago

Why Is Immuron Stock (IMRN) Down Today?


Immuron anounces new DoD award and clinical trial updates

2025-12-03T11:10:43.000Z - 7 months ago

Immuron anounces new DoD award and clinical trial updates


Immuron announces FDA approval of IND for IMM-529

2025-11-05T11:25:57.000Z - 8 months ago

Immuron announces FDA approval of IND for IMM-529


Immuron: FDA Approves IND Application For IMM-529

2025-11-05T11:25:02.000Z - 8 months ago

Immuron: FDA Approves IND Application For IMM-529


Immuron IMM-529 IND approved by FDA

Wed, 05 Nov 2025 06:00:00 -0500 - 8 months ago

Immuron IMM-529 IND approved by FDA


Immuron Announces Rise In Global Revenue For Q1

2025-10-13T12:54:51.000Z - 8 months ago

Immuron Announces Rise In Global Revenue For Q1


Immuron Q1 FY26 YoY growth

Mon, 13 Oct 2025 06:00:00 -0400 - 8 months ago

Immuron Q1 FY26 YoY growth


Why Immuron Is Rising In Pre-market?

2025-10-08T10:16:00.000Z - 9 months ago

Why Immuron Is Rising In Pre-market?


Immuron Submits IMM-529 IND to FDA

Wed, 08 Oct 2025 06:00:00 -0400 - 9 months ago

Immuron Submits IMM-529 IND to FDA


Immuron (IMRN) Updates Shareholders on Key Project Developments

2025-10-02T11:26:44.000Z - 9 months ago

Immuron (IMRN) Updates Shareholders on Key Project Developments


Immuron announces projects update

2025-10-02T10:20:08.000Z - 9 months ago

Immuron announces projects update


Immuron Letter to Shareholders – Projects Update

Thu, 02 Oct 2025 06:00:00 -0400 - 9 months ago

Immuron Letter to Shareholders – Projects Update


Immuron enters partnership with InvestorHub

2025-08-27T09:20:17.000Z - 10 months ago

Immuron enters partnership with InvestorHub


Immuron partners with InvestorHub

Tue, 26 Aug 2025 22:29:00 -0400 - 10 months ago

Immuron partners with InvestorHub


Immuron - FY25 global sales exceed projection, up 49% on prior year

Thu, 17 Jul 2025 06:00:00 -0400 - 1 year ago

Immuron - FY25 global sales exceed projection, up 49% on prior year


Immuron Letter to Shareholders: Projects Update

Fri, 30 May 2025 06:00:00 -0400 - 1 year ago

Immuron Letter to Shareholders: Projects Update


Immuron (IMRN) Achieves Record Sales Milestone

2025-04-11T08:55:40.000Z - 1 year ago

Immuron (IMRN) Achieves Record Sales Milestone


Immuron Travelan® highest sales in history

Thu, 10 Apr 2025 18:00:00 -0400 - 1 year ago

Immuron Travelan® highest sales in history


Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Wed, 05 Mar 2025 06:00:00 -0500 - 1 year ago

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)


Immuron reports strong sales growth of Travelan

2025-01-17T11:10:11.000Z - 1 year ago

Immuron reports strong sales growth of Travelan


Immuron Travelan® continued strong sales growth

Fri, 17 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Travelan® continued strong sales growth


Immuron announces Travelan clinical trial update

2025-01-14T11:10:34.000Z - 1 year ago

Immuron announces Travelan clinical trial update


Immuron Announces Travelan® Clinical Trial Update

Tue, 14 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Announces Travelan® Clinical Trial Update


Immuron reports Q3 sales of Travelan up 13% vs. Q2

2024-10-15T10:10:20.000Z - 1 year ago

Immuron reports Q3 sales of Travelan up 13% vs. Q2


Immuron Travelan® continued strong sales growth

Tue, 15 Oct 2024 06:00:00 -0400 - 1 year ago

Immuron Travelan® continued strong sales growth


Immuron trading halted, news pending

2024-10-02T23:10:07.000Z - 1 year ago

Immuron trading halted, news pending


Immuron initiated with a Buy at Litchfield Hills

2024-09-26T13:25:16.000Z - 1 year ago

Immuron initiated with a Buy at Litchfield Hills


Immuron Ltd Webinar Presentation Transcript

2024-09-14T11:17:07.000Z - 1 year ago

Immuron Ltd Webinar Presentation Transcript


Immuron plans Phase 2 trial for IMM-529 following FDA review

2024-09-05T16:00:45.000Z - 1 year ago

Immuron plans Phase 2 trial for IMM-529 following FDA review


Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Sep 5, 2024, 11:54 AM EDT - 1 year ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review


Immuron announces new DoD research award for NMRC

2024-08-16T10:02:59.000Z - 2 years ago

Immuron announces new DoD research award for NMRC


Immuron announces record Travelen sales globally

2024-07-15T12:10:03.000Z - 2 years ago

Immuron announces record Travelen sales globally


Immuron requests pre-IND meeting for IMM-529 with FDA filing

Jul 2, 2024, 6:00 AM EDT - 2 years ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing


Immuron Board Changes

May 31, 2024, 6:00 AM EDT - 2 years ago

Immuron Board Changes


Immuron CEO Steven Lydeamore to present at Peak Sky High

May 31, 2024, 6:00 AM EDT - 2 years ago

Immuron CEO Steven Lydeamore to present at Peak Sky High


Immuron Limited to Present at the Emerging Growth Conference

May 7, 2024, 6:00 AM EDT - 2 years ago

Immuron Limited to Present at the Emerging Growth Conference


Immuron Director Resignation

May 3, 2024, 6:00 AM EDT - 2 years ago

Immuron Director Resignation


Immuron to host Live Virtual Event

Apr 15, 2024, 6:00 AM EDT - 2 years ago

Immuron to host Live Virtual Event


Immuron Travelan® sales continued strong growth

Apr 10, 2024, 6:00 AM EDT - 2 years ago

Immuron Travelan® sales continued strong growth


Immuron Presentation Australian Biologics Festival 2024

Feb 21, 2024, 6:00 AM EST - 2 years ago

Immuron Presentation Australian Biologics Festival 2024


Immuron achieves record Travelan® sales

Feb 13, 2024, 6:00 AM EST - 2 years ago

Immuron achieves record Travelan® sales


Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Feb 8, 2024, 6:00 AM EST - 2 years ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation


Immuron achieves record half yearly Travelan® sales

Jan 16, 2024, 6:00 AM EST - 2 years ago

Immuron achieves record half yearly Travelan® sales


Immuron Clinical Trials Update

Dec 22, 2023, 6:00 AM EST - 2 years ago

Immuron Clinical Trials Update


Immuron CEO Steven Lydeamore Investor Webinar Presentation

Nov 13, 2023, 6:00 PM EST - 2 years ago

Immuron CEO Steven Lydeamore Investor Webinar Presentation


Immuron CEO Steven Lydeamore presented at AusBioInvest

Oct 30, 2023, 7:21 AM EDT - 2 years ago

Immuron CEO Steven Lydeamore presented at AusBioInvest


Immuron Announces Travelan® Clinical Study Cohort 2 commences

Oct 18, 2023, 6:00 AM EDT - 2 years ago

Immuron Announces Travelan® Clinical Study Cohort 2 commences


Immuron achieves record quarterly Travelan® sales

Oct 11, 2023, 6:00 AM EDT - 2 years ago

Immuron achieves record quarterly Travelan® sales


Immuron achieves record monthly Travelan® sales

Sep 13, 2023, 6:00 AM EDT - 3 years ago

Immuron achieves record monthly Travelan® sales


Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

Sep 11, 2023, 6:00 AM EDT - 3 years ago

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright


SuperGreenToday
SuperGreenToday Jun. 17 at 8:11 AM
1 · Reply
Tryitin
Tryitin Jun. 16 at 10:06 PM
$IMRN 4 hr candle is showing double bottom at 1.05 and has been consolidating above 1 for the past 2+ weeks. A rise here is imminent in the coming days/weeks with or without news.
0 · Reply
VikaDelic
VikaDelic Jun. 12 at 1:04 PM
$IMRN short interest will update again based on end of today. Someone isn’t finding shares and is losing their patience, probably try to whipsaw it before they begin paying for what they can’t find with fud tactics. Very limited playbook when you look at the shares available and borrow rates, especially after the Australian exchange sent the inquiry recently about unusual trading. Ask yourself why someone would risk manipulating a stock under 10 mil with multiple DOD contracts recently awarded, something is probably coming that justified the risk
0 · Reply
Tryitin
Tryitin Jun. 10 at 3:18 PM
$IMRN Absolutely. This is consolidating heavily above 1.1 levels just like last time before it raised heavily. Round 2 is in the corner in the coming days. PAYtience will pay here!
1 · Reply
VikaDelic
VikaDelic Jun. 10 at 1:12 PM
$IMRN wow- 532000 shares short! 10 days to cover. Less than 100K shares to borrow going on a week now, borrow rate still over 30% ⏰ tick tock
0 · Reply
Tryitin
Tryitin Jun. 6 at 3:04 PM
$IMRN Absolutely. Even inspite of thick red market, this had a strong 4 hr green candle. Consistent higher lows chart pattern in a bullish wedge and is consolidating for the next leg up in the coming days IMO.
0 · Reply
KUMO2026
KUMO2026 Jun. 6 at 10:21 AM
$IMRN very nice short on this manufactured poop stock the irony play pills may prevent poopy pants, but the stock took a big ugly dump like i said it would im never wrong kids
1 · Reply
Tryitin
Tryitin Jun. 5 at 1:09 PM
$IMRN Absolutely. Just a matter of time. 1.2 is good support and should reverse from there IMO.
1 · Reply
t_baggin_u
t_baggin_u Jun. 4 at 4:37 AM
$IMRN So you're the new board pumper now? Welcome. But that won't change much.
0 · Reply
Tryitin
Tryitin Jun. 3 at 7:41 PM
$IMRN Need some volume or action here. Looks better than yesterday close. Wen news PR drop on this one? Lets Go!
0 · Reply
VikaDelic
VikaDelic Jun. 2 at 4:07 PM
$IMRN ADR’s aren’t going to R/S 🤣 love the idiots who don’t understand dual exchange dynamics. There was no R/S my sad friend. Nearly a point a week that shorts are paying to borrow… now that’s something real
1 · Reply
GhostOfFrankie4Fingers
GhostOfFrankie4Fingers Jun. 2 at 3:57 PM
$IMRN Could also go sub dollar because it’s a 💩 company fresh off a 1/10 reverse split.
0 · Reply
VikaDelic
VikaDelic Jun. 2 at 3:01 PM
$IMRN borrow rates began exploding a few days ago, someone isn’t finding shares and is getting desperate 😳
0 · Reply
KUMO2026
KUMO2026 Jun. 2 at 2:33 PM
$IMRN nice short here
1 · Reply
VikaDelic
VikaDelic Jun. 2 at 2:21 PM
$IMRN hard to get rich shorting a stock that is profitable and also has expanding govt intellectual property portfolio that is fully funded. There is 10x more money to be made on the way up. Just a matter of time…
0 · Reply
NinoBlackCity
NinoBlackCity Jun. 2 at 2:18 PM
$IMRN 💩
0 · Reply
Tryitin
Tryitin Jun. 1 at 7:59 PM
$IMRN Remember this raised sharply AH last week from 1 to 1.92 levels and I think a raise like that is coming again here someday soon IMO. I can clearly see it through chart patterns. Lets Go!
0 · Reply
Baseball89
Baseball89 Jun. 1 at 5:45 PM
$IMRN this one could very easily go to $18 with such a low float.
0 · Reply
KUMO2026
KUMO2026 Jun. 1 at 2:54 PM
$IMRN added to short 1.59
0 · Reply
NinoBlackCity
NinoBlackCity Jun. 1 at 2:16 PM
0 · Reply
Tryitin
Tryitin Jun. 1 at 2:09 PM
$IMRN This pumped from 1.2 to 1.5 levels Friday on low volume., Next leg here is about to start here on low volume pump which will take this from 1.5 to 1.9+ levels in a day or two......chart pattern and consolidation is clear for the uprise IMO. Lets Go!
0 · Reply
Baseball89
Baseball89 Jun. 1 at 2:05 PM
$IMRN good visibility.... Strong sales profitable year after year. I like it.
0 · Reply